Diethyl L-glutamate Hydrochloride (CAS 1118-89-4) Ultimate Product Guide
Table of Contents
- 1. Product Specifications & Comparative Analysis
- 2. Industrial Applications & Functional Mechanisms
- 3. Operational Protocols & Handling Guidelines
- 4. Verified Application Case Studies
- 5. Client Implementation Scenarios
- 6. Expert Consultation & Technical Support
1. Product Specifications & Comparative Analysis
| Parameter | Diethyl L-glutamate HCl | Ethyl L-glutamate | L-Glutamic Acid |
|---|---|---|---|
| CAS Number | 1118-89-4 | N/A | 56-86-0 |
| Molecular Formula | C9H17NO4·HCl | C7H13NO4 | C5H9NO4 |
| Purity Grade | Pharma Grade (≥99%) | Industrial Grade (95-98%) | Food Grade (85-99%) |
| Solubility | Water: 50mg/mL | Water: Insoluble | Water: 7.5g/100mL |
2. Industrial Applications & Functional Mechanisms
Pharmaceutical Synthesis: Critical intermediate in nootropic drugs production including aniracetam and brivaracetam. Enables precise stereochemical control in CNS-active compounds.
Biochemical Research: Chiral building block for peptide synthesis and neurotransmitter studies. Particularly valuable in NMDA receptor modulation research.
Industrial Catalysis: Serves as asymmetric catalyst in enantioselective Mannich reactions (up to 92% ee achieved).
3. Operational Protocols & Handling Guidelines
Storage Conditions: Maintain at 2-8°C in airtight containers with nitrogen blanket. Shelf life: 36 months when unopened.
Reconstitution: Use deoxygenated ethanol-water (7:3 v/v) for optimal solubility. Avoid phosphate buffers due to precipitation risks.
Safety Profile: Non-flammable but hygroscopic. Use NIOSH-approved respirators when handling powders.
4. Verified Application Case Studies
Case 1: European Pharma Manufacturer (2023)
Achieved 22% yield improvement in racetam derivative synthesis through optimized diethyl ester protection strategy.
Case 2: US Research Consortium (2022)
Developed novel Alzheimer’s drug candidates using our HCl salt formulation for enhanced blood-brain barrier penetration.
5. Client Implementation Scenarios
Client A: Top-10 Global CRO
Annual consumption: 850kg
Application: High-throughput screening of neurological compounds
Outcome: Reduced chiral separation costs by 40%
Client B: Japanese API Producer
Batch size: 200-300kg
Process: Continuous flow synthesis optimization
Benefit: Achieved 99.7% chiral purity consistently
6. Expert Consultation & Technical Support
Contact our chemistry specialists for:
- Custom synthesis scale-up protocols
- Regulatory compliance documentation (EDMF, CEP)
- Stability studies data packages
Email: info@vivalr.com
Phone: (86) 15866781826
Office Hours: Mon-Fri 08:00-17:00 GMT+8



评论
目前还没有评论。